V016-5011 Screening compound: 3-(2H-1,3-benzodioxole-5-amido)-N-[1-(4-fluorobenzoyl)piperidin-4-yl]pyrazine-2-carboxamide

V016-5011 Screening compound: 3-(2H-1,3-benzodioxole-5-amido)-N-[1-(4-fluorobenzoyl)piperidin-4-yl]pyrazine-2-carboxamide
V016-5011 Screening compound: 3-(2H-1,3-benzodioxole-5-amido)-N-[1-(4-fluorobenzoyl)piperidin-4-yl]pyrazine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V016-5011
3-(2H-1,3-benzodioxole-5-amido)-N-[1-(4-fluorobenzoyl)piperidin-4-yl]pyrazine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V016-5011

Molecular Formula

C25H22FN5O5 (C25 H22 FN5 O5)

Compound Name

3-(2H-1,3-benzodioxole-5-amido)-N-[1-(4-fluorobenzoyl)piperidin-4-yl]pyrazine-2-carboxamide

IUPAC name

3-(2H-13-benzodioxole-5-amido)-N-[1-(4-fluorobenzoyl)piperidin-4-yl]pyrazine-2-carboxamide

SMILES

O=C(c(cc1)cc2c1OCO2)Nc1nccnc1C(NC(CC1)CCN1C(c(cc1)ccc1F)=O)=O

InChI

InChI=1S/C25H22FN5O5/c26-17-4-1-15(2-5-17)25(34)31-11-7-18(8-12-31)29-24(33)21-22(28-10-9-27-21)30-23(32)16-3-6-19-20(13-16)36-14-35-19/h1-6,9-10,13,18H,7-8,11-12,14H2,(H,29,33)(H,28,30,32)

InChI Key

YPGFFWPWCGEXIH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19906883

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

491.48

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.794

Distribution Coefficient, logD

1.507

Water Solubility, LogSw

-2.25

Polar Surface Area

100.546

Acid Dissociation Constant (pKa)

7.43

Base Dissociation Constant (pKb)

-1.87

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

V016-5011 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V016-5011 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V016-5011?
Check Price and Availability of V016-5011, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V016-5011 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V016-5011
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V016-5011
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V016-5011 available by request